The modification of proteins by reducing sugars through the process of non-enzymatic glycation is one of the principal mechanisms by which hyperglycaemia may precipitate the development of diabetic complications. Fn3K (fructosamine 3-kinase) and Fn3KRP (Fn3K-related protein) are two recently discovered enzymes that may play roles in metabolizing early glycation products. However, although the activity of these enzymes towards various glycated substrates has been established, very little is known about their structure-function relationships or their respective mechanisms of action. Furthermore, their only structural similarities noted to date with members of other kinase families has been with the bacterial aminoglycoside kinases. In the present study, we employed affinity labelling with the ATP analogue FSBA {5 -p-[(fluorosulfonyl)benzoyl]adenosine} to probe the active-site topology of Fn3KRP as an example of this enigmatic family of kinases. FSBA was found to modify Fn3KRP at five distinct sites; four of these were predicted to be localized in close proximity to its ATP-binding site, based on alignments with the aminoglycoside kinase APH(3 )-IIIa, and examination of its published tertiary structure. The results of the present studies provide evidence that Fn3KRP possesses an ATP-binding domain that is structurally related to that of both the aminoglycoside kinases and eukaryotic protein kinases.
INTRODUCTION
One of the mechanisms proposed to underlie the development of diabetic complications is the modification of proteins through the process of non-enzymatic glycation [1] . Under physiological conditions, reducing sugars can covalently modify primary amine groups of proteins through the Maillard reaction. In this process, proteins are initially modified through the nucleophilic addition of glucose, resulting in the formation of a Schiff base. This product subsequently undergoes a slower, spontaneous rearrangement to generate a more stable ketosamine or Amadori product [1, 2] . Formation of these initial products is reversible, and proceeds at a rate proportional to ambient glucose concentrations. However, both Schiff base and fructosamine products can subsequently participate in a range of irreversible fragmentation and oxidation reactions, ultimately leading to the formation of a heterogeneous group of modified protein species, collectively referred to as AGEs (advanced glycation end-products) (reviewed in [3] ).
Until recently, very little was known of the in vivo mechanisms acting in eukaryotic organisms to suppress the accumulation of glycation adducts, and in particular the Amadori product. The previously described enzymes, Fn3K (fructosamine 3-kinase) [4, 5] and Fn3KRP (Fn3K-related protein) [6] (also referred to as ketosamine kinases 1 and 2), are believed to be the first examples of deglycating enzymes acting on the Amadori product to reverse the early stages of the Maillard reaction in vivo in higher organisms [7] . Fn3K and Fn3KRP are homologous proteins sharing approx. 65 % sequence identity. Fn3K catalyses the phosphorylation of protein-bound fructosamines on the third carbon of the sugar moiety. This modification generates a labile fructosamine 3-phosphate which then decomposes spontaneously, resulting in regeneration of the unmodified protein together with formation of 3-deoxyglucosone and release of inorganic phosphate [4] . Fn3K was identified originally in human erythrocytes through its ability to phosphorylate sorbitol and fructose substrates leading to production of sorbitol-3-phosphate and fructose-3-phosphate respectively [4, 8, 9] . Knockout mice in which Fn3K expression is ablated reportedly exhibit increased accumulation of protein-bound fructosamines, supporting a physiological role of this kinase in modulating the levels of early glycation adducts in vivo [10] . Interestingly, despite a high degree of sequence conservation between Fn3K and Fn3KRP, the latter is unable to phosphorylate either synthetic or proteinbound fructosamines, but instead is active towards substrates glycated in vitro with either ribose or allose (ribulosamines or psicosamines respectively) [6] . Also, Fn3KRP exhibits a unique substrate stereospecificity with regard to glucitolamine substrates where it phosphorylates the C-4 hydroxy group [11] . These observations suggest that, although Fn3KRP possesses an intrinsic activity towards ketosamine substrates, it may participate in other cellular functions that involve as yet unidentified physiological substrates unrelated to non-enzymatic glycation [11] .
In the context of the known activities of the currently described families of eukaryotic kinases, phosphorylation of protein-bound ketosamines by Fn3K and Fn3KRP represent unique substrate specificities. No significant sequence homology between Fn3K and Fn3KRP, and other eukaryotic kinases has been reported, and their tertiary structures are currently unknown. BLAST searches have revealed a population of microbial sequences encoding Abbreviations used: DTT, dithiothreitol; ESI, electrospray ionization; Fn3K, fructosamine 3-kinase; Fn3KRP, Fn3K-related protein; FSBA, 5 -p-[(fluorosulfonyl)benzoyl]adenosine; MS/MS, tandem MS; SBA, sulfonylbenzoyl adenosine; TEV, tobacco etch virus; TOF, time-of-flight. 1 To whom correspondence should be addressed (email k.loomes@auckland.ac.nz).
proteins of unknown function sharing approx. 30 % sequence identity with human Fn3K [5] . These gene products are annotated as either hypothetical ketosamine kinases or as aminoglycoside kinases, the latter of which confer bacterial resistance to a wide range of aminoglycoside antibiotics [12] . The tertiary structure of the microbial aminoglycoside kinase APH(3 )-IIIa has been elucidated, and the nucleotide-binding domain has been described [13] . This enzyme inactivates aminoglycoside substrates through an ATP-dependent O-phosphorylation mechanism [14] . Sequence alignments of representative ketosamine kinases reveal a number of conserved residues including Lys 41 , Glu 55 and Asp 244 , as well as a conserved DxxxxN motif extending from residue 227 to 232 in the Fn3KRP primary structure. The corresponding residues in APH(3 )-IIIa are located in the ATP-binding site of this enzyme, and have been implicated as having important roles in catalysis [13] .
In order to probe the active-site topology of the ketosamine kinases, and to investigate the apparent similarities with the microbial aminoglycoside kinases, we utilized affinity labelling with the ATP analogue FSBA {5 -p-[(fluorosulfonyl)benzoyl]adenosine}. We found that FSBA modified several residues that are predicted to lie within the ATP-binding domain based on homology with the aminoglycoside kinases. The results of the present study also suggest that the ketosamine kinases possess a nucleotide-binding domain similar to that of the eukaryotic protein kinases, despite minimal global sequence conservation.
MATERIALS AND METHODS

Cloning and expression of recombinant human Fn3KRP
Full-length cDNA was obtained from a lung carcinoma (SHP77) cell line by RT-PCR using primers 5 -GTATCCATGGAGGAGCT GCTGAGGC-3 and 5 -GCATGAATTCTCACTTGACCAGATT CG-3 , which included NcoI and EcoRI restriction sites respectively. PCR products were ligated into the pFastBac TM HTb vector (Invitrogen) through NcoI and EcoRI sites in the multiple cloning site [in frame with the vector-encoded hexahistidine tag and rTEV (where TEV is tobacco etch virus) protease cleavage site]. Recombinant bacmid vector was produced by transformation of DH10 Bac TM Escherichia coli with the resulting pFastBac TM HTb/Fn3KRP construct. Production of recombinant baculovirus stocks was achieved by transfecting Sf9 cells with purified recombinant bacmid DNA using Cellfectin reagent. The resulting P1 viral stock was amplified prior to use in protein expression studies, and the amount of viral stock required to achieve the phenotypic characteristics of late-stage infection at 72 h after initiation of infection stock was determined empirically using 10 ml cultures. For large-scale protein expression, fresh cultures of Sf9 cells were seeded so that they were at a density of approx. 2 × 10 6 cells/ml after overnight incubation. Recombinant baculovirus stock was added to the cells at a dilution of 1:500-1:2000 (v/v). Following infection with recombinant baculovirus, cells were incubated at 28
• C with continuous agitation until phenotypic characteristics of late-stage viral infection were observed (approx. 72 h). Cells at the late stage of infection were harvested by centrifugation (1000 g for 15 min at 4
• C; Sorvall SLA-3000 rotor). Pelleted cells were resuspended in 8 ml of PBS containing protease inhibitors (Roche Complete EDTA-free) and transferred to a 50 ml Falcon Tube. Cells were then spun at 800 g in a Sorvall RTH-750 rotor for 10 min at 4
• C, and the supernatant was removed. Pelleted cells were resuspended in an equal volume of PBS containing protease inhibitors and the resulting cell paste was frozen at − 80
• C.
Purification of recombinant Fn3KRP
Unless otherwise stated, recombinant Fn3KRP was affinitypurified from cleared cell lysates using Talon cobalt resin (Clontech) equilibrated with 50 mM Tris/HCl (pH 8.0). Bound proteins were eluted with 50 mM Tris/HCl (pH 8.0), containing 80 mM imidazole, 50 mM NaCl and 5 % (v/v) glycerol. Fractions containing Fn3KRP were desalted using a HiTrap TM desalting column (GE Healthcare) and the recombinant protein was further purified by anion-exchange chromatography using Q-Sepharose equilibrated with 10 mM Tris/HCl (pH 8.0) and 1 mM DTT (dithiothreitol), and eluted with a linear gradient of 0-500 mM NaCl. Purified recombinant Fn3KRP was desalted into 10 mM Tris/HCl (pH 8.0) containing 1 mM DTT, concentrated, and stored in aliquots at − 80
Limited trypsin digest
A (20 mg/ml) stock trypsin (Promega) solution was used to make a 0.5 mg/ml trypsin solution and an appropriate volume was added to 100 μg of recombinant Fn3KRP (37 • C) in 50 mM Tris/HCl (pH 8.0), to give a final ratio of 1:50 (w/w; trypsin/protein). Following trypsin addition, aliquots were taken at indicated times, mixed with an equal volume of 2 × SDS loading buffer [160 mM Tris/HCl, 4 % (w/v) SDS, 20 % glycerol, 1.66 M 2-mercaptoethanol and 0.3 % Bromophenol Blue] and incubated at 95
• C for 5 min to inhibit protease activity. Samples were then analysed by SDS/PAGE.
CD
Recombinant Fn3KRP purified as described above was bufferexchanged into 20 mM potassium phosphate (pH 7.8) at a final protein concentration of 116 μg/ml using a HiTrap TM desalting column. CD measurements were carried out using a Pi-Star 180 spectrometer (Applied Photophysics). Readings were taken at room temperature (20 • C).
Measurement of ketosamine kinase activity
Fn3KRP activity was measured through incorporation of radioactive phosphate from [γ -32 P]ATP into the sugar moiety of lysozyme previously glycated with either allose or ribose. Reactions contained 25 mM Tris/HCl (pH 7.8), 2.1 mg/ml riboseor psicose-lysozyme, 100 μM ATP, 1 mM DTT, 1 mM EGTA, 0.5 mM MgCl 2 and 0.25 μCi of [γ -32 P]ATP (Amersham) in a final volume of 50 μl. Reaction mixtures were pre-incubated at 30
• C for at least 2 min, and reactions were initiated by addition of Fn3KRP. Reactions were terminated by spotting 20 μl aliquots of the reaction mixture on to 1.5 cm 2 pieces of P81 paper (Whatman), which were immediately transferred to a beaker containing ice-cold 75 mM phosphoric acid. Papers were washed at least five times in ice-cold phosphoric acid and twice in ice-cold ethanol before being transferred to scintillation vials containing 2 ml of scintillation fluid (Packard Starscint). For each assay, negative control reactions containing no enzyme were also performed. Additional negative control reactions containing no substrate or native (non-glycated) lysozyme were also included where required. For detection of the phosphorylated product by autoradiography, 0.21 mg/ml of psicose-lysozyme was phosphorylated as described above. After 30 min, 20 μl of reaction mix was removed, mixed with 4 × SDS-sample buffer, and analysed by SDS/PAGE. Gels were sealed in zip-locked bags and radioactive protein bands were visualised by overnight exposure on X-ray film (RPN 3114K, Amersham).
Preparation of glycated lysozyme
Glycated lysozyme was synthesized according to the method of Collard et al. [6] . Briefly, a solution containing 25 mM Hepes (pH 7.1), 60 mg/ml hen egg lysozyme (Sigma) and 1 M ribose (Baker) or allose (Sigma) was sterilized by filtration through a 0.2 μm syringe filter into sterile cryovials. Tubes were sealed, and incubated at 37
• C for 3 or 21 days for ribose or allose respectively. Reactions were stopped by desalting on a HiTrap desalting column equilibrated with Milli-Q water. Glycated proteins were stored at − 20
• C until further analysis and use. Qualitatively, formation of protein-bound ketosamines was confirmed by formation of a characteristic blue/black formazan precipitate when aliquots of the desalted glycation reaction mixture were added to a solution containing 100 mM Na 2 CO 3 (pH 10.8) and 0.25 mM Nitro Blue Tetrazolium. In addition, desalted products were characterized by ESI (electrospray ionization)-TOF (time-of-flight) MS.
Affinity labelling of Fn3KRP with FSBA
Purified Fn3KRP was incubated with 0.5 mM FSBA in a solution containing 25 mM Tris/HCl (pH 7.8), 5 mM MgCl 2 and 10 % DMSO in the presence or absence of ATP. For activity assays, reactions were stopped by diluting aliquots of the labelling reactions in the kinase assay reaction buffer. For MS analysis, reactions were stopped at the indicated times by desalting on Zeba micro-desalting columns equilibrated with 100 mM ammonium bicarbonate.
MS
For MALDI (matrix-assisted laser-desorption ionization)-TOF MS, proteolytic fragments of proteins of interest were mixed with an equal volume of matrix [10 mg/ml α-CHC (α-cyano-4-hydroxycinnamic acid; Sigma) dissolved in 0.3 % TFA (trifluoroacetic acid) and 50 % (v/v) acetonitrile], spotted on to sample plates and allowed to dry. Peptides were analysed on a Voyager DE Pro mass spectrometer running Voyager Instrument Control Panel and Data Explorer software (Applied Biosystems). The instrument was used in reflector mode with an ion-acceleration potential of 20 kV. Final spectra were an average of 100 shots. External calibration was performed using synthetic peptides (Cal Mix 1, Applied Biosystems).
For analysis of whole proteins and acquisition of sequence data, protein samples were analysed using a Q-STAR XL Hybrid MS/MS (tandem MS) mass spectrometer (Applied Biosystems). The system was configured with an ESI source in-line with the Ultimate Capillary/Nano LC system (Dionex). Digests were separated at 6 μl/min on a Zorbax SB300 C 18 0. Table 1 .
Statistics
Non-linear regression and one-way ANOVA with Tukey's posthoc test were performed using GraphPad Prism software. P values of < 0.05 were considered significant and all tests were two-tailed.
RESULTS AND DISCUSSION
Expression and characterization of recombinant human Fn3KRP
Recombinant Fn3KRP, labelled with an N-terminal His 6 tag, was purified by cobalt affinity followed by anion-exchange chromatography. Fn3KRP eluted from anion-exchange medium as a single peak early in the salt gradient and was essentially pure as analysed by SDS/PAGE ( Figure 1A ). Attempts to remove the His 6 tag through cleavage at the rTEV site were unsuccessful and purified Fn3KRP therefore retained this additional moiety. MS analyses of protein bands excised from SDS/PAGE gels confirmed the identity of the purified protein as Fn3KRP. Interrogation of the experimentally derived mass spectra using the MASCOT search yielded Fn3KRP as the only statistically significant 'hit' from the Swiss-Prot protein data base, confirming the identity of the purified protein.
Computational protein folding predictions using the program FoldIndex suggested that Fn3KRP was mostly folded except for the presence of two unfolded regions from residues 1 to 40 and 175 to 183. CD spectrometry confirmed that recombinant Fn3KRP was well folded ( Figure 1B) . The spectrum was consistent with a mostly α-helical conformation as analysed using the SOMCD method [15] . ESI-TOF analysis of the intact protein returned a molecular mass that differed from the theoretical molecular mass based on the primary structure by approx. 89 Da. This is probably due to loss of the N-terminal methionine residue and subsequent acetylation of the adjacent serine residue. This hypothesis was supported by ESI-TOF MS/MS analysis of Fn3KRP tryptic digests ( Figure 1C and Table 1 ) and the observation that similar modifications have also been reported to occur for other proteins expressed in Sf9 cells [16, 17] .
Domain structure
To analyse Fn3KRP stability and protein folding, limited trypsin digest experiments were performed (Figure 2 ). The 36 kDa Fn3KRP band (lane 3) was cleaved into two fragments of approx. 19 kDa and 15 kDa (lane 4) within 30 s of trypsin exposure. These two fragments did not undergo further degradation over 2 h in the presence of trypsin (lanes 4-11) . This observation agreed with protein folding predictions (using FoldIndex) which identified one of the small unfolded regions near the centre of the amino acid sequence (residues 175-183) and which contained a trypsin cleavage site. Cleavage by trypsin within this region would yield two peptides almost identical in size with those observed in the present experiment. The lack of further trypsin proteolysis of the 19 and 15 kDa bands further suggests that both products were well folded. When purified Fn3KRP was stored at room temperature for 1 week, the protein did not spontaneously degrade into these two smaller fragments, suggesting that it is otherwise stable. These results are consistent with the hypothesis that Fn3KRP and APH(3 )-IIIa have a conserved domain structure consisting of well-ordered N-and C-terminal lobes, with high α-helical content, linked by a less tightly folded region [13] .
Enzyme activity
The activity of purified, recombinant Fn3KRP was confirmed by monitoring the incorporation of radiolabelled phosphate from [γ -
32 P]ATP into lysozyme previously glycated in vitro with allose ( Figure 3 ). Prior analysis of this substrate by ESI-TOF MS demonstrated approx. 3 mol of sugar incorporated per mol of substrate. In radioactive kinase assays, recombinant Fn3KRP exhibited the expected catalytic activity towards psicoselysozyme ( Figure 3A ) whereas no significant activity towards unmodified lysozyme was detected, indicating that the observed activity was specific for the covalently attached sugar moiety. Similar results were also obtained using lysozyme glycated in vitro with ribose (results not shown).
Autoradiographic detection of the phosphorylated substrate in the reaction with psicose-lysozyme confirmed the identity of the radiolabelled product ( Figure 3B ). A K m of 420 + − 81 μM was calculated using a derived value of 3 mol of psicosamine residues per mol of lysozyme, as measured by MS analysis ( Figure 3C ). This value is in relatively good agreement with a previously reported K m of 270 μM for free psicose-lysine, measured using recombinant human Fn3KRP expressed in human embryonic kidney cells [6] . Although we cannot completely discount the possibility that the histidine tag altered the activity, these results indicate that the Fn3KRP we used in the present study was functional and fundamentally unaffected by its presence. Furthermore, this finding demonstrates that the baculovirus expression system is suitable for expression of milligram quantities of catalytically functional Fn3KRP. It is also worth noting that the difference in the apparent K m of the enzyme for psicose-lysine measured in the present study and that reported by Collard et al. [6] is probably due to the respective substrates used. In contrast with free psicose-lysine, not all psicosamine residues in the glycated lysozyme substrate would be expected to be accessible to the Fn3KRP active site. In addition, local charge effects may influence the relative affinity for psicosamine residues at different sites in the lysozyme substrate.
Inactivation of Fn3KRP by FSBA
FSBA has been used previously to probe residues involved in nucleotide binding in a number of kinases, including the aminoglycoside kinase, APH(3 )-IIIa, whose crystal structure has also been reported [18] [19] [20] . FSBA is structurally related to ATP (Figure 4) , and most commonly modifies nucleophilic groups in close proximity to nucleotide-binding sites of enzymes by the covalent addition of an SBA group, resulting in a mass increase of approx. 433 Da [21] . Incubation of 0.7 mg/ml Fn3KRP with 0.5 mM FSBA resulted in significant activity 3 and 4) . The molecular mass in kDa is indicated on the left-hand side. (C) Substrate-activity curve for psicose-lysozyme. Rates are the means + − S.E.M. for three independent experiments each performed in duplicate. The substrate concentrations given refer to the concentrations of psicose-lysine moieties calculated on the basis of 3 mol of psicose residues incorporated per mol of lysozyme protein as measured by ESI-TOF analysis. The K m and V max were 420 + − 81 μM and 183.2 + − 12.7 pmol/min per μg respectively.
loss compared with controls (Table 2 ). Subsequent treatment of the inactivated enzyme with DTT did not restore activity. This suggests that inactivation was not due to FSBA-catalysed disulfide-bond formation, which has been reported in enzymes possessing adjacent cysteine residues in close proximity to an ATP-binding site [22] . Addition of a 10-fold molar excess of ATP to samples of Fn3KRP incubated with FSBA significantly attenuated inactivation of the enzyme, strongly suggesting that FSBA inactivates Fn3KRP by modification of residues at the nucleotide-binding site (Table 2) . Interestingly, however, complete attenuation of Fn3KRP inhibition was not achieved even when a 20-fold molar excess of ATP was included in labelling reactions. Further investigation of the time course of inactivation of Fn3KRP by FSBA revealed that, in the absence of ATP, enzyme inhibition occurred rapidly, with a maximal effect apparent after 10-15 min ( Figure 5 ). ESI-TOF analysis of intact Fn3KRP showed that accumulation of SBA adducts continued throughout the incubation period, with formation of several distinct modified species. After 5 min, a mixture of unmodified, singly and doubly modified species were identified. By contrast, after 1 h, Fn3KRP existed as a mixture of species containing between 1 and 5 mol of the SBA label per mol of protein and no unmodified protein was detected. By contrast, addition of a 10-fold excess of ATP substantially suppressed incorporation of the label, in that unmodified protein along with singly and doubly modified species were detected at 1 h; no species containing 4 or 5 mol/mol of SBA were observed under these conditions. These findings suggest that, under the conditions employed, FSBA modifies multiple residues spatially close to the ATP-binding site.
In order to determine the sites of modification, reaction mixtures were stopped after either 5 min or 1 h incubation with FSBA, then digested with trypsin and the resultant peptides were analysed by ESI-TOF MS. A summary of modified residues detected at different time points with or without a 10-fold molar excess of ATP are summarized in Table 3 . Five peptides containing sulfonyl benzoic acid adducts (derived from ester hydrolysis of SBA) were identified exclusively in tryptic digests of FSBA-modified Fn3KRP. Interestingly, no intact SBA adducts were detected. This finding was somewhat unexpected since tryptic digests were performed under near neutral pH, whereas cleavage of the ester linkage of the SBA moiety is generally considered to occur under acidic conditions [23] . However, subsequent analysis revealed that hydrolysis of the SBA moiety did indeed occur during incubation of the FSBA-modified enzyme in the buffer employed for tryptic digests. Using this approach, residues identified as modified by FSBA were Tyr 33 , Lys 41 , Lys 45 , His 90 and Lys 269 . Consistent with the protection conferred by ATP, no modified residues were identified after a 5 min incubation of Fn3KRP with FSBA in the presence of ATP. Interestingly, as discussed further below, From the alignment of the primary structures of Fn3KRP and of APH(3 )-IIIa, and comparison with the published tertiary structure of APH(3 )-IIIa [13, 24] , four of the five labelled amino acid residues identified in Fn3KRP were found to correspond to APH(3 )-IIIa residues located in close proximity to the ATPbinding site ( Figure 6 ). Figure 6A ). This residue is adjacent to APH(3 )-IIIa Lys 33 , which is a site of FSBA modification reported for this enzyme ( Figure 6B ) [20] . Fn3KRP Lys 41 aligns with Lys 44 of APH(3 )-IIIa ( Figure 6A ), which is also another site of FSBA modification reported for this enzyme [20] . Lys 44 is involved in co-ordination of the γ -phosphate of ATP in APH(3 )-IIIa ( Figure 6B ) [13] , and conservation of this residue across hypothetical ketosamine kinases from various species is consistent with an important role in the catalytic mechanism. Mapping of the residues of APH(3 )-IIIa, corresponding to Lys Figure 6B ). The significance of this is unclear, but it probably represents a nonspecific modification, which may account for the inability of an excess of ATP to completely protect against inactivation of Fn3KRP by FSBA.
Overall, these results demonstrate similarities between the ketosamine kinase and aminoglycoside kinase families of enzymes with regard to conservation of residues involved in ATP-binding and phosphotransferase activity. Consequently, the tertiary structures of the ketosamine kinases, similar to the aminoglycoside kinases, are likely to be arranged around an ATPbinding site, which is formed in a cleft between an N-terminal lobe and a slightly larger C-terminal lobe [13] . Given this information, more detailed analysis of the alignment shown in Figure 6 , in the context of residues that are known to be involved in catalysis in APH(3 )-IIIa, revealed the presence of further conserved residues that probably play a role in ATP binding by Fn3KRP. As mentioned previously, and supported by FSBA labelling, Lys 41 in Fn3KRP corresponds to the conserved 'invariant' Lys 44 in APH(3 )-IIIa. Likewise, Fn3KRP Glu 55 is also conserved and corresponds to APH(3 )-IIIa Glu 60 ( Figure 6A ). In APH(3 )-IIIa, both of these residues are involved in ATP capture [13, 25] [13, 25] . Given the alignment data presented, and the data obtained from affinity labelling experiments in the present study, it is likely that these residues provide similar roles in the ketosamine kinases. Interestingly, although no notable sequence homology between the ketosamine kinases and protein kinases has been reported, these active site residues are also conserved in the serine/threonine and tyrosine kinases [13, 26] .
In summary, affinity labelling of Fn3KRP with FSBA provides experimental evidence for a conserved active site topology between the ketosamine kinases and the aminoglycoside kinases. Corresponding sequence alignments show that a number of conserved catalytic residues involved in ATP-binding and phosphoryl transfer in the aminoglycoside kinases are also modified by FSBA in Fn3KRP. Additionally, these results suggest that a degree of homology also exists between the eukaryotic protein kinases and the ketosamine kinases with respect to their active site architecture.
